Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Participants With Relapsing Multiple Sclerosis (RMS) or Primary Progressive Multiple Sclerosis (PPMS)
-
Autoimmune Disorder -
Multiple Sclerosis (MS) -
Primary Progressive Multiple Sclerosis (PPMS) -
Neurodegenerative Disorder -
Relapsing Multiple Sclerosis (RMS)
For the latest version of this information please go to www.forpatients.roche.com